ES2146200T3 - Medicamentos inducidos peritonealmente. - Google Patents

Medicamentos inducidos peritonealmente.

Info

Publication number
ES2146200T3
ES2146200T3 ES91905304T ES91905304T ES2146200T3 ES 2146200 T3 ES2146200 T3 ES 2146200T3 ES 91905304 T ES91905304 T ES 91905304T ES 91905304 T ES91905304 T ES 91905304T ES 2146200 T3 ES2146200 T3 ES 2146200T3
Authority
ES
Spain
Prior art keywords
solution
peritoneally
hyaluronic acid
induced drugs
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905304T
Other languages
English (en)
Inventor
Zerega Gere S Di
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Application granted granted Critical
Publication of ES2146200T3 publication Critical patent/ES2146200T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UNA SOLUCION DE ACIDO HIALURONICO Y SALES SOLUBLES EN AGUA DEL MISMO EN UN MEDIO FARMACEUTICAMENTE ACEPTABLE EN EL QUE LA CONCENTRACION DE ACIDO HIALURONICO ES DE AL MENOS ALREDEDOR DEL 0.4% EN BASE AL PESO TOTAL DE LA SOLUCION Y LA SOLUCION TIENE UNA VISCOSIDAD A 25 (GRADOS) C DE ENTRE 500 Y 10000 "CENTIPOISES", LA SOLUCION SIRVE COMO PORTADOR PARA MEDICAMENTOS PARA LA CAVIDAD PERITONEAL.
ES91905304T 1990-02-13 1991-02-06 Medicamentos inducidos peritonealmente. Expired - Lifetime ES2146200T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47911190A 1990-02-13 1990-02-13

Publications (1)

Publication Number Publication Date
ES2146200T3 true ES2146200T3 (es) 2000-08-01

Family

ID=23902703

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905304T Expired - Lifetime ES2146200T3 (es) 1990-02-13 1991-02-06 Medicamentos inducidos peritonealmente.

Country Status (7)

Country Link
US (1) US6284744B1 (es)
EP (1) EP0589871B1 (es)
AU (1) AU7312291A (es)
DE (1) DE69132145T2 (es)
ES (1) ES2146200T3 (es)
WO (1) WO1991011992A1 (es)
ZA (1) ZA911063B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
ATE306903T1 (de) 1995-03-24 2005-11-15 Genzyme Corp Verminderung von adhäsionen durch gesteuerte verabreichung von aktivsauerstoffinhibitoren
DE10064219B9 (de) 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
JP2008259704A (ja) * 2007-04-12 2008-10-30 Hisamitsu Pharmaceut Co Inc プレフィルド型シリンジ

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB769287A (en) * 1954-08-18 1957-03-06 American Home Prod Preparation of partially depolymerized hyaluronic acid and therapeutic compositions thereof
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
FR2553099B1 (fr) * 1983-10-11 1989-09-08 Fidia Spa Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
JPS6084225A (ja) * 1983-10-17 1985-05-13 Hiroko Shimizu 点眼剤
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
EP0244178A3 (en) * 1986-04-28 1989-02-08 Iolab, Inc Intraocular dosage compositions and method of use
US5080893A (en) * 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
US5140016A (en) * 1988-05-31 1992-08-18 University Of Florida Method and composition for preventing surgical adhesions using a dilute solution of polymer
CA1341093C (en) * 1988-05-31 2000-09-05 Eugene P. Goldberg Method and composition for preventing surgical adhesions
JPH03215430A (ja) * 1990-01-19 1991-09-20 Kita Kiyoshi 関節腔抗凝固剤
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease

Also Published As

Publication number Publication date
AU7312291A (en) 1991-09-03
EP0589871A4 (en) 1992-11-17
DE69132145D1 (de) 2000-05-31
EP0589871B1 (en) 2000-04-26
ZA911063B (en) 1991-12-24
US6284744B1 (en) 2001-09-04
DE69132145T2 (de) 2000-09-21
EP0589871A1 (en) 1994-04-06
WO1991011992A1 (en) 1991-08-22

Similar Documents

Publication Publication Date Title
DE69637441D1 (de) Verabreichung unlöslicher arzneistoffe
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
ES8602404A1 (es) Metodo de producir complejos solubles en agua de principios activos insolubles en agua y fosfolipidos
AR012927A1 (es) Una composicion farmaceutica, una forma de dosificacion farmaceutica, el uso de dicha composicion para la fabricacion de un medicamento y una forma depresentacion farmaceutica adecuada para la venta comercial
ES2052016T3 (es) Composicion emulsionada.
CO4480020A1 (es) Formulaciones farmaceuticas
ES2159524T3 (es) Preparacion farmaceutica para administrarse en el interior de las vias respiratorias.
AR025962A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que los contienen
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
BR0012901A (pt) Medicamentos de ß - carbolina
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
ES2137353T3 (es) Nuevos derivados esteroides especificos del colon o del ileon.
ES2045363T3 (es) Utilizacion de una composicion dietetica para la inhibicion de la adhesion celular.
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
ES2146200T3 (es) Medicamentos inducidos peritonealmente.
CO5170467A1 (es) Capsulas de eter de celulosa libres de turbiedad y proceso para hacer las mismas
AR038373A1 (es) Sistema de suministro osmotico
ATE138380T1 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
ATE90872T1 (de) Immunostimulierende arzneimittel.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
ATE70445T1 (de) Pharmazeutische praeparate.
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 589871

Country of ref document: ES